JP2019533713A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533713A5
JP2019533713A5 JP2019524887A JP2019524887A JP2019533713A5 JP 2019533713 A5 JP2019533713 A5 JP 2019533713A5 JP 2019524887 A JP2019524887 A JP 2019524887A JP 2019524887 A JP2019524887 A JP 2019524887A JP 2019533713 A5 JP2019533713 A5 JP 2019533713A5
Authority
JP
Japan
Prior art keywords
composition according
composition
pah
riociguat
sgc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019524887A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019533713A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/061116 external-priority patent/WO2018089804A1/en
Publication of JP2019533713A publication Critical patent/JP2019533713A/ja
Publication of JP2019533713A5 publication Critical patent/JP2019533713A5/ja
Priority to JP2022185917A priority Critical patent/JP2023029865A/ja
Priority to JP2025084398A priority patent/JP2025131627A/ja
Pending legal-status Critical Current

Links

JP2019524887A 2016-11-10 2017-11-10 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 Pending JP2019533713A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022185917A JP2023029865A (ja) 2016-11-10 2022-11-21 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法
JP2025084398A JP2025131627A (ja) 2016-11-10 2025-05-20 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662420515P 2016-11-10 2016-11-10
US62/420,515 2016-11-10
US201762530533P 2017-07-10 2017-07-10
US62/530,533 2017-07-10
PCT/US2017/061116 WO2018089804A1 (en) 2016-11-10 2017-11-10 Methods of treating pah with combinations of ralinepag and other agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022185917A Division JP2023029865A (ja) 2016-11-10 2022-11-21 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法

Publications (2)

Publication Number Publication Date
JP2019533713A JP2019533713A (ja) 2019-11-21
JP2019533713A5 true JP2019533713A5 (https=) 2020-12-17

Family

ID=60451197

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019524887A Pending JP2019533713A (ja) 2016-11-10 2017-11-10 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法
JP2022185917A Pending JP2023029865A (ja) 2016-11-10 2022-11-21 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法
JP2025084398A Pending JP2025131627A (ja) 2016-11-10 2025-05-20 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022185917A Pending JP2023029865A (ja) 2016-11-10 2022-11-21 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法
JP2025084398A Pending JP2025131627A (ja) 2016-11-10 2025-05-20 ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法

Country Status (11)

Country Link
US (2) US12377067B2 (https=)
EP (2) EP3538154B1 (https=)
JP (3) JP2019533713A (https=)
KR (4) KR20260020212A (https=)
CN (2) CN119367341A (https=)
AU (3) AU2017357759A1 (https=)
CA (1) CA3043283A1 (https=)
ES (1) ES3052035T3 (https=)
IL (2) IL266518B1 (https=)
MA (1) MA46750A (https=)
WO (1) WO2018089804A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12377067B2 (en) 2016-11-10 2025-08-05 Arena Pharmaceuticals, Inc. Methods of treating PAH with combinations of ralinepag and other agents
IL268997B2 (en) 2017-03-01 2023-09-01 Arena Pharm Inc Preparations containing pgi2 receptor agonists and processes for their preparation
EP3796902A1 (en) * 2018-05-16 2021-03-31 Arena Pharmaceuticals, Inc. Compositions comprising pgi2-receptor agonists and processes for the preparation thereof
CN108721296B (zh) * 2018-07-03 2019-04-05 中国人民解放军总医院 一种化合物在治疗或预防高原病中的用途
WO2020048299A1 (zh) * 2018-09-06 2020-03-12 广东东阳光药业有限公司 药物共晶体及其制备方法
PT3897646T (pt) 2018-12-21 2024-07-08 Actelion Pharmaceuticals Ltd Macitentano para tratamento de hipertensão arterial pulmonar
TW202042818A (zh) * 2019-01-25 2020-12-01 瑞士商艾克泰聯製藥有限公司 用於治療慢性血栓性肺高血壓之醫藥組成物
WO2023154705A1 (en) * 2022-02-08 2023-08-17 United Therapeutics Corporation Treprostinil iloprost combination therapy
WO2023158634A1 (en) 2022-02-15 2023-08-24 United Therapeutics Corporation Crystalline prostacyclin (ip) receptor agonist and uses thereof
US20250282716A1 (en) 2024-03-11 2025-09-11 United Therapeutics Corporation Methods of making ip-receptor agonists
CN121714543A (zh) * 2024-09-23 2026-03-24 上海欣药智能科技有限公司 一种可吸入的含可溶性鸟苷酸环化酶受体激动剂的药物组合物及其用途
US12582629B1 (en) * 2025-10-23 2026-03-24 Innovate Therapeutics Llc Extended-release pharmaceutical compositions of Ralinepag

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2085844A1 (en) 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
GB9908934D0 (en) 1999-04-19 1999-06-16 Rolic Ag Liquid crystalline compounds
US20040048844A1 (en) 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
WO2002055484A1 (en) 2001-01-12 2002-07-18 Takeda Chemical Industries, Ltd. Biaryl compound, process for producing the same, and agent
WO2003007888A2 (en) 2001-07-20 2003-01-30 Adipogenix, Inc. Fat accumulation-modulating compounds
CN101284773A (zh) 2001-08-09 2008-10-15 小野药品工业株式会社 羧酸衍生物及以它为活性成分的药剂
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
TWI293715B (en) 2002-10-10 2008-02-21 Sipix Imaging Inc A method for inducing or enhancing the threshold of an electrophoretic display, an electrophoretic fluid and an electrophoretic display
RU2351590C2 (ru) 2003-02-10 2009-04-10 Вертекс Фармасьютикалз Инкорпорейтед Способ получения диариламина
GB0325291D0 (en) * 2003-10-29 2003-12-03 Pfizer Ltd Novel combination
JP2008510726A (ja) 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド プロテイナーゼ活性化受容体アンタゴニストを含む組成物および方法
WO2007051255A1 (en) 2005-11-04 2007-05-10 The University Of Sydney Process for the preparation of compounds containing an azacyclic ring system
US20080075692A1 (en) 2006-05-09 2008-03-27 Perrine Susan P Methods for treating blood disorders
WO2009117095A1 (en) 2008-03-18 2009-09-24 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US20110224262A1 (en) 2008-11-26 2011-09-15 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
ES2548882T3 (es) 2008-12-08 2015-10-21 Arena Pharmaceuticals, Inc. Moduladores del receptor de prostaciclina (PGl2) útiles para el tratamiento de trastornos relacionados con los mismos
WO2011037613A1 (en) * 2009-09-23 2011-03-31 Arena Pharmaceuticals, Inc. Crystalline forms and processes for the preparation of pgi2 receptor agonists
US9388154B2 (en) * 2011-09-12 2016-07-12 Lund Biotechnology PBC Process for preparing synthetic prostacyclins
AU2013351934B2 (en) * 2012-11-30 2018-03-29 Insmed Incorporated Prostacylin compositions and methods for using the same
US10537546B2 (en) * 2014-10-23 2020-01-21 Arena Pharmaceuticals, Inc. Method of treating conditions related to the PGI2 receptor
CN107427698A (zh) * 2015-01-13 2017-12-01 维瓦斯公司 肺高血压的组合疗法
US12377067B2 (en) 2016-11-10 2025-08-05 Arena Pharmaceuticals, Inc. Methods of treating PAH with combinations of ralinepag and other agents

Similar Documents

Publication Publication Date Title
JP2019533713A5 (https=)
JP2022058688A5 (https=)
JP2021098727A5 (https=)
JP2024540183A5 (https=)
JP2018193377A5 (https=)
AR060931A1 (es) Producto farmaceutico recubierto para la administracion intraoral de nicotina y su uso y elaboracion
JP2019081811A5 (https=)
JP2005512995A5 (https=)
JP2017513809A5 (https=)
JP2006525328A5 (https=)
JP2024512425A5 (https=)
JP2021073257A5 (https=)
JP2009517411A5 (https=)
RU2016147008A (ru) Жидкие композиции метформина с пролонгированным высвобождением
JP2007513913A5 (https=)
JP2022531251A5 (https=)
JP2015522603A5 (https=)
JP2013528649A5 (https=)
JP2021516241A5 (https=)
JP2016501208A5 (https=)
KR20110068985A (ko) 변형 방출 라미프릴 조성물 및 그것의 사용
CN101642444B (zh) 单硝酸异山梨酯双速渗透泵型控释制剂及其制备方法
RU2018104691A (ru) Композиции с модифицированным высвобождением ницерголина
JP2023531930A5 (https=)
CN1224354A (zh) 肺循环改善剂